References
- Acland R D. Microsurgery practice manual. St. Mosby, Louis 1980; 58–59
- Agnelli G, Buchanan M, Fernandez F. A comparison of the thrombolytic and haemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. Circulation 1985; 72: 178–182
- Arnljots B, Wieslander J B, Dougan P, Salemark L. Prevention of microvascular thrombosis with low-dose tissue plasminogen activator. Plast Reconstr Surg 1992; 90: 281–288
- Fitzgerald D J, Catella F, Roy L, Fitzgerald G A. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 1988; 77: 142–150
- GISSI-2: A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 1990; 336: 65–71
- ISIS-3: A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753–770
- Mattsson C, Nilsson S, Häggroth L. Human extrinsic plasminogen activator. Fibrinolytic properties and neutralization in vivo. Thromb Res 1983; 30: 91–100
- Nilsson I M, Olow B. Fibrinolysis induced by streptokinase in man. Acta Chir Scand 1962; 123: 247–266
- Nunn B, Esmail A, Fears R, Ferres H, Standring R. Pharmacokinetic properties of anisoylated plasminogen streptokinase activator complex and other thrombolytic agents in animals and in humans. Drugs 1987; 33(3)88–92, Suppl
- Ohlstein E H, Storer B, Fujita T, Shebuski R J. Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit. Thromb Res 1987; 46: 575–585
- Runge M S, Quertermous T, Haber E. Plasminogen actiators: The old and the new. Circulation 1989; 79: 217–224
- Salemark L. An international survey of current microvascular practices in free tissue transfer and replantation surgery. Microsurgery 1991; 12: 308–311
- Terres W, Umnus S, Mathey D G, Bleifeld W. Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates. Cardiiovasc Res 1990; 24: 471–477
- Urokinase-Streptokinase pulmonary embolism trial. J Am Med Assoc 1974; 229: 1606–1613
- Wieslander J B, Dougan P. Washout of vessels with heparin does not improve patency following severe experimental trauma. Ann Plast Surg 1990; 24: 216–222